Inspiration Healthcare Group PLC Investor presentation
13 Junio 2023 - 8:00AM
RNS Non-Regulatory
TIDMIHC
Inspiration Healthcare Group PLC
13 June 2023
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Investor presentation
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology company pioneering best-in class, specialist neonatal
intensive care medical devices, announces that Neil Campbell, CEO
and Alan Olby, CFO of Inspiration Healthcare Group plc will provide
a live presentation to investors via the Investor Meet Company
platform on Monday, 19 June 2023 at 3pm BST. The presentation will
give an update on the Company and an overview of the recent
preliminary results released in May.
The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via the Investor
Meet Company dashboard up until 9am the day before the meeting or
at any time during the live presentation. Investors can sign up to
Investor Meet Company for free and add to meet Inspiration
Healthcare.
To register for the presentation, please use this link:
https://www.investormeetcompany.com/inspiration-healthcare-group-plc/register-investor
Investors who already follow Inspiration Healthcare on the
Investor Meet Company platform will automatically be invited.
For further information, please contact:
Inspiration Healthcare Group plc Tel: +44 (0)330 175 0000
Neil Campbell, Chief Executive Officer
Alan Olby, Chief Financial Officer
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
Relations)
Anna Dunphy Mob: +44 (0) 7876 741 001
Stephanie Cuthbert Mob: +44 (0) 7796 794 663
Louis Ashe-Jepson Mob: +44 (0) 7747 515 393
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in neonatal intensive care &
operating theatres. The Company provides high quality innovative
products to patients around the world which help to improve patient
outcomes and it actively invests in innovative product
opportunities and disruptive technologies.
The Company has key own brand products that can be used within
the first days of life to help premature and sick babies; helping
resuscitation and stabilisation in the first moments of life
through to preventing brain damage and both invasive and
non-invasive respiratory support in terms of capital equipment and
disposable medical devices. Additionally, the Company has its own
range of products for maintaining normothermia pre, during and
post-surgery.
Since September 2019, the Company has acquired Vio Holdings a
designer, manufacturer and supplier of single use respiratory
products and sterile medical consumables and S.L.E., a leading
designer, manufacturer and global provider of neonatal ventilation
products. The Group generates approximately 58% of its revenues
from export markets and more than half of its revenues come from
its own-branded products.
With product availability actively promoted to over 80 countries
through a distribution network, Inspiration Healthcare's success
has been built on continuous innovation, excellent customer service
and an inherent commitment to improving patient outcomes, working
in close collaboration with key opinion leaders across the
globe.
In the UK and Ireland, the Group has direct sales teams selling
Group Branded and complementary products from third parties, with
an additional range of home healthcare products. This is supported
by Technical Support for planned preventative maintenance and
emergency assistance.
The Group operates from various sites in the UK for R&D,
Marketing and operations with manufacturing based in Croydon (south
London) and Hailsham (East Sussex). The Group's Head Office is
located in Crawley, a short distance from London's Gatwick
Airport.
Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEAAKDFSSDEFA
(END) Dow Jones Newswires
June 13, 2023 09:00 ET (13:00 GMT)
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De May 2023 a May 2024